About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Lung Cancer Clinical Trials | 7,985 Studies Recruiting

Clinical TrialsLung Cancer

Lung Cancer Clinical Trials

Browse 7,985 clinical trials for lung cancer. Find studies that match your criteria and connect with research centers.

Find trials near:

New York Los Angeles Chicago Houston Phoenix Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 1521-1540 of 7,985 trials

RecruitingPreoperative Amivantamab or Amivantamab and Carboplatin/Pemetrexed Treatment in Patients With Resectable Non-small-cell Lung Cancer Harboring Oncogenic EGFR Mutations (NEOpredict-EGFR)The primary objective of this study is to determine the feasibility of four weeks of preoperative antibody therapy with amivantamab.NCT06784791·Hasselt and 3 others CompletedPET CT Re-Planning NSCLC (4DCT-PET)This study will see whether the addition of more frequent planning CTs during the course of radiation, and of Positron Emission Tomography (PET), a diagnostic test similar to CT…NCT03403127 RecruitingClinical Utility of ctDNA in Detecting Resistance Mechanisms and Delivering Precision Medicine to Cancer PatientsctDNA stands for circulating tumour DNA.NCT07673861·London

Related Searches

nsclctrials sclctrials lung carcinomatrials

Data from ClinicalTrials.govTerms

UnknownObservational Study of the Efficacy and Safety of Anlotinib Combined With Penpulimab in Elderly Lung Cancer PatientsThis prospective observational study will evaluate the efficacy and safety of anlotinib in combination with Penpulimab in elderly patients with lung cancer.NCT05319886·Xinxiang, Henan

CompletedDeciphering Afatinib Response and Resistance With INtratumour HeterogeneityTo assess if targeting activating EGFR and HER2 mutations in Non-Small Cell Lung Cancer (NSCLC) is more effective when these mutations are truncal dominant mutations (≥50%), as…NCT02183883·Aberdeen and 6 others

TerminatedA Study of TPX-0131, a Novel Oral ALK Tyrosine Kinase Inhibitor, in Patients With ALK+ Advanced or Metastatic NSCLCA phase 1, first-in-human, open-label study to evaluate the safety, tolerability, PK, and efficacy of the novel ALK inhibitor TPX-0131 in pretreated subjects with ALK+ advanced or…NCT04849273·Orange, California and 14 others

CompletedEnsartinib in Non-small Cell Lung Cancer Patients With Positive ALKThis study is aimed to determine the maximum tolerated dose of ensartinib, an oral ALK inhibitor in Chinese patients with ALK-positive non-small cell lung cancerNCT02959619·Guanzhou, Guangdong

Active not recruitingTesting the Addition of an Anti-Cancer Drug, TRC102, to the Usual Chemotherapy Treatment (Pemetrexed, Cisplatin or Carboplatin) During Radiation Therapy for Stage III Non-Squamous Non-Small Cell Lung CancerThis phase II trial tests whether TRC102 (methoxyamine hydrochloride) in combination usual care treatment comprised of pemetrexed, cisplatin or carboplatin, and radiation therapy…NCT05198830·Buena Park, California and 33 others

CompletedEffect of Low Molecular Weight Heparin: Tinzaparin in Lung Tumours (TILT)Experiments suggest that low molecular weight heparin (LMWH) inhibits tumor growth and metastasis.NCT00475098·Paris

WithdrawnStudy of Front Line Pembrolizumab and Valemetostat in PD-L1 Positive, HPV-Negative Recurrent/Metastatic Squamous Cell Carcinoma (SCC) of the Head and Neck: The PANTHERASBackground: Head and neck squamous cell carcinoma (HNSCC) is the 6th most common cancer worldwide.NCT05879484·Bethesda, Maryland

RecruitingAllogeneic PB103 (NK Cells) Therapy in Non-small Cell Lung Cancer (NSCLC) PatientsObjectives: To determine the safety, tolerability, and efficacy of allogeneic PB103 in patients with IIIb/IV or refractory non-small-cell lung cancerNCT04616209·Taipei

UnknownTo Evaluate the Efficacy and Safety of Gefitinib in Adjuvant Chemotherapy for Lung AdenocarcinomaThe purpose of this study was to evaluate the efficacy and safety of targeted gefitinib versus oral vinorelbine and carboplatin in EGFR-mutant NSCLC patients.NCT03656393·Shenzhen, Guangdong

CompletedConcurrent and Non-concurrent Chemo-radiotherapy or Radiotherapy Alone With Intensity-modulated Radiotherapy (IMRT) for Non Small Cell Lung Cancer (NSCLC) to an Individualised Mean Lung Dose (MLD)Our group has shown that increasing the radiation dose to pre-specified normal tissue dose constraints could lead to increased TCP with the same NTCP in patients with…NCT01166204·Maastricht, Limburg

RecruitingStudy of Treatment With Sacituzumab and Zimberelimab for Patients With Lung Cancer Confined to the Chest and Previously Operated on Who Were Not Disease-free.Open-label, phase III, randomized, stratified (PDL1- vs PDL1+), 3 arms, multicenter clinical trial.NCT06431633·Alicante, Alicante and 31 others

CompletedCarboxyamidotriazole and Paclitaxel in Treating Patients With Advanced Solid Tumors or Refractory LymphomasRATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. Combining more than one drug may kill more cancer cells.NCT00019019·Bethesda, Maryland and 1 other

CompletedA Safety and Tolerability Study of INCAGN02385 in Select Advanced MalignanciesThe purpose of this study is to determine the safety, tolerability, and preliminary efficacy of INCAGN02385 in participants with advanced malignancies.NCT03538028·Los Angeles, California and 3 others

RecruitingStudy on the Mechanism of Acquired Resistance of EntrectinibThe goal of this observational study is to learn about the mechanism of acquired resistance in first line trearment of ROS1-positive NSCLC with entrectinib.NCT07199959·Shanghai, Shanghai Municipality

CompletedPaclitaxel and Carboplatin With or Without Celecoxib Before Surgery in Treating Patients With Stage IIIA Non-Small Cell Lung CancerRATIONALE: Drugs used in chemotherapy such as paclitaxel and carboplatin use different ways to stop tumor cells from dividing so they stop growing or die.NCT00062179·Los Angeles, California and 1 other

Not yet recruitingBPI-361175 Tablets in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)This is a three-stage study, consisting of Phase Ia dose-escalation, Phase Ib dose expansion, and a Phase II component.NCT05393466

UnknownFurmonertinib in Patients With Leptomeningeal Metastases Associated With EGFR Mutated NSCLCThe goal of this clinical trial is to evaluate the clinical efficacy and safety of Furmonertinib in EGFR mutated NSCLC patients with leptomeningeal metastasis and to explore the…NCT05813522·Hangzhou, Zhejiang

PreviousPage 77 of 400Next